Compare IRON & AMBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | AMBA |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.0B |
| IPO Year | N/A | N/A |
| Metric | IRON | AMBA |
|---|---|---|
| Price | $94.29 | $77.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $108.83 | $97.25 |
| AVG Volume (30 Days) | 533.0K | ★ 1.2M |
| Earning Date | 11-06-2025 | 11-25-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $373,850,000.00 |
| Revenue This Year | N/A | $39.65 |
| Revenue Next Year | N/A | $9.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 48.08 |
| 52 Week Low | $30.82 | $38.86 |
| 52 Week High | $97.12 | $96.69 |
| Indicator | IRON | AMBA |
|---|---|---|
| Relative Strength Index (RSI) | 62.96 | 45.06 |
| Support Level | $87.18 | $68.79 |
| Resistance Level | $96.18 | $73.46 |
| Average True Range (ATR) | 3.94 | 4.68 |
| MACD | -0.32 | -1.15 |
| Stochastic Oscillator | 56.25 | 33.25 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.